It’s estimated that nearly one in 7 U.S. adults have been diagnosed with sinusitis in the past 12 months, which occurs when the mucous membranes in your nose and sinuses become irritated. In most of these cases (90-98%) a virus is the cause, whereas in 2-10% of cases, a bacterial infection is also present.These bacterial infections are becoming increasingly drug-resistant and therefore harder and harder to treat, which is why the Infectious Diseases Society of America (IDSA) recently issued new treatment guidelines for sinusitis.
Alarmingly, however, buried on page 16 of their report is the acknowledgement that certain hard-to-treat bacterial infections in children are on the rise because of the widespread use of the conjugated pneumococcal vaccines!
Bacterial Infections on the Rise Since Introduction of the Pneumonia Vaccine
The IDSA report states:
” … both the prevalence of H. influenzae (40%– 45%) and proportion of b-lactamase–producing H. influenzae (37%–50%) (extrapolated from middle ear fluid cultures of children with acute otitis media) have markedly increased among other upper respiratory tract infections since the widespread use of conjugated pneumococcal vaccines… Whereas S. pneumoniae was more common than H. influenzae prior to 2000, the prevalence of H. influenzae has clearly increased while that of S. pneumoniae has decreased in the post–pneumococcal vaccine era, such that currently they are approximately equal … “
In the United States the Prevnar vaccine, which is used to prevent pneumoccocal disease that can cause meningitis and bloodstream infections in young children, was licensed in 2000 and has been given to infants in four